| Application no. and date | 13701871.9 (espacenet) (Federated) (European Patent Register), 20130125 | | Patent/reg. no. and date | DK/EP 2806892, 20190306 | | Publication date | 20141203 | | Priority no. and date | GB 201201314, 20120126 | | EP pub. no. and date |
EP 2806892 20141203 | | Effective date | | | Applicant/owner | Hansa Biopharma Limited , Mount Manor House
16 the Mount, Guildford
Surrey GU2 4HN, GB | | Applicant ref. no. | P81902371DK00E | | Inventor | CRISPIN, Matthew David Max, Teme Place
Teme Road
Cheltenham GL52 6UE, GB,
SCANLAN, Christopher Neil, -----
deceased, GB | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , C07K 16/32 (2006.01) , C12N 9/24 (2006.01) | | Title | Kombineret terapeutisk anvendelse af antistoffer og endoglycosidaser | | Int. application no. | GB2013050164 | | Int. publication no. | WO2013110946 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
